Literature DB >> 5048236

Carcinogenicity of amosite asbestos.

I J Selikoff, E C Hammond, J Churg.   

Abstract

Mesh:

Substances:

Year:  1972        PMID: 5048236     DOI: 10.1080/00039896.1972.10666158

Source DB:  PubMed          Journal:  Arch Environ Health        ISSN: 0003-9896


× No keyword cloud information.
  13 in total

1.  Asbestos and cancer: history and public policy.

Authors:  W K Morgan
Journal:  Br J Ind Med       Date:  1992-06

2.  Production of reactive oxygen metabolites induced by asbestos fibres in human polymorphonuclear leucocytes.

Authors:  M Hedenborg; M Klockars
Journal:  J Clin Pathol       Date:  1987-10       Impact factor: 3.411

Review 3.  The spectrum of asbestos-related diseases.

Authors:  W N Rom; P E Palmer
Journal:  West J Med       Date:  1974-07

Review 4.  Does asbestos exposure cause gastrointestinal cancer?

Authors:  D S Levine
Journal:  Dig Dis Sci       Date:  1985-12       Impact factor: 3.199

Review 5.  Diffuse malignant mesothelioma: a review.

Authors:  W N Rom; J E Lockey
Journal:  West J Med       Date:  1982-12

6.  Mesothelioma possibly due to environmental exposure to asbestos in childhood.

Authors:  K J Arul; P F Holt
Journal:  Int Arch Occup Environ Health       Date:  1977-11-09       Impact factor: 3.015

7.  Tyler asbestos workers: mortality experience in a cohort exposed to amosite.

Authors:  J L Levin; J W McLarty; G A Hurst; A N Smith; A L Frank
Journal:  Occup Environ Med       Date:  1998-03       Impact factor: 4.402

8.  Asbestos and gastrointestinal cancer. A review of the literature.

Authors:  R W Morgan; D E Foliart; O Wong
Journal:  West J Med       Date:  1985-07

9.  Mortality of chrysotile asbestos workers at the Balangero Mine, Northern Italy.

Authors:  G F Rubino; G Piolatto; M L Newhouse; G Scansetti; G A Aresini; R Murray
Journal:  Br J Ind Med       Date:  1979-08

10.  Inorganic particles in human tissues and their association with neoplastic disease.

Authors:  A M Langer
Journal:  Environ Health Perspect       Date:  1974-12       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.